AI-generated summary
The authors report a case series of 12 hospitalized children aged 0 to 12 with skin injuries, treated with a device emitting blue light at 410 to 430 nm every three days. Complete healing occurred in 11 of 12 cases, with an average healing time of 3.7 days, and no side effects were observed. The authors note that more structured clinical trials are needed to validate efficacy.
- Participants
- 12
- Who or what was studied
- Twelve hospitalized pediatric patients aged 0 to 12 years with skin injuries including incontinence-associated dermatitis, peristomal injuries, and pressure injuries.
- Wavelengths
- 410, 430 nm
- Limits stated in the abstract
- The study is an observational case series with a small sample and no control group, and the authors state that structured clinical trials are needed to validate efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background/Objectives
Pediatric skin injuries represent a clinical challenge, especially in cases with complex etiology or with severe pain. Blue light is an emerging technology with potential application in pediatric wound care. The aim of this case series was to describe the clinical use of blue light in pediatric patients with injuries of varying etiologies and mechanisms, and to assess its long-term effectiveness and sustainability in treatment.
Methods
Twelve hospitalized pediatric patients (0-12 years old) with skin injuries were included in this case series. The etiologies of wounds treated with photobiomodulation were incontinence-associated dermatitis, peristomal injuries, and pressure injuries. The injuries were assessed using specific classification tools and pain scales. The wounds were treated every three days using a medical device that emits blue light (410-430 nm). When necessary, wounds were also treated with appropriate dressings.
Results
All injuries responded positively to photobiomodulation therapy and showed a rapid resolution of inflammation. Complete wound resolution was achieved in 11 of 12 cases. The average healing time was 3.7 days. Four injuries achieved resolution with only one application of blue light. Scores from the pain perception scales showed that the blue light treatment was well tolerated by pediatric patients, showing high parental compliance. No side effects or adverse events were observed.
Conclusions
Blue light photobiomodulation proved to be a safe, well-tolerated, and effective technology in the treatment of pediatric skin injuries, with good acceptance by young patients and families. More structured clinical trials would be needed to validate the efficacy of blue light in pediatric injuries.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 410-430 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.